Fujita-Yamashita Manami, Yamamoto Koichiro, Honda Hiroyuki, Hanayama Yoshihisa, Tokumasu Kazuki, Nakano Yasuhiro, Hasegawa Kou, Hagiya Hideharu, Obika Mikako, Ogawa Hiroko, Otsuka Fumio
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JPN.
Cureus. 2021 Sep 18;13(9):e18070. doi: 10.7759/cureus.18070. eCollection 2021 Sep.
Objectives Vitamin D deficiency, which is common worldwide, increases the risks of falls and fractures and can lead to increased morbidity and mortality. However, the clinical utility and relevance of vitamin D activation remain unknown. The aim of the present study was to clarify the clinical usefulness of serum 1,25-dihydroxyvitamin D (1,25D)/25-hydroxyvitamin D (25D) ratio for assessment of the extent of bone metabolism. Methods We retrospectively screened data for 87 patients whose serum 1,25D and 25D levels were measured. Eight patients who were taking vitamin D preparations were excluded, and data for 79 patients (33 males and 46 females) were analyzed. Since menopausal status can be associated with serum vitamin D level, we divided the patients by gender and divided the female patients into two groups at the age of 50 years. Results The median serum 1,25D/25D ratio was significantly lower in males than in females, with the most considerable difference in all males [4.1 (interquartile range: 2.3-5.8) × 10] versus elderly females (aged ≧50 years) [7.9 (3.3-10.1) × 10). Main disorders were endocrine (30.6%), inflammatory (18.5%), and bone-related (16.7%) disorders. The ratios of serum 1,25D/25D had significant negative correlations with femoral dual-energy X-ray absorptiometry % young adult mean (DEXA %YAM) (-0.35) and lumbar DEXA %YAM (-0.32). Significant correlations were found between the 1,25D/25D ratio and serum levels of inorganic phosphate (iP), parathyroid hormone, and alkaline phosphatase (ALP). The 1,25D/25D ratio had gender-specific characteristics: the ratio was significantly correlated with age in males (-0.49), while it was significantly correlated with BMI in females (0.34). Conclusions The results of this study suggested that vitamin D activity is negatively correlated with bone mineral density, being reduced in aged males but enhanced in obese females.
目的 维生素D缺乏在全球范围内普遍存在,会增加跌倒和骨折的风险,并可能导致发病率和死亡率上升。然而,维生素D活化的临床效用和相关性仍不明确。本研究的目的是阐明血清1,25 - 二羟维生素D(1,25D)/25 - 羟维生素D(25D)比值在评估骨代谢程度方面的临床实用性。方法 我们回顾性筛选了87例测定血清1,25D和25D水平的患者的数据。排除8例正在服用维生素D制剂的患者,分析79例患者(33例男性和46例女性)的数据。由于绝经状态可能与血清维生素D水平相关,我们按性别对患者进行分组,并将女性患者在50岁时分为两组。结果 男性血清1,25D/25D比值中位数显著低于女性,所有男性[4.1(四分位间距:2.3 - 5.8)×10]与老年女性(年龄≧50岁)[7.9(3.3 - 10.1)×10]之间差异最为显著。主要疾病为内分泌疾病(30.6%)、炎症性疾病(18.5%)和骨相关疾病(16.7%)。血清1,25D/25D比值与股骨双能X线吸收法年轻成人均值百分比(DEXA %YAM)(-0.35)和腰椎DEXA %YAM(-0.32)呈显著负相关。1,25D/25D比值与无机磷(iP)、甲状旁腺激素和碱性磷酸酶(ALP)的血清水平之间存在显著相关性。1,25D/25D比值具有性别特异性特征:该比值在男性中与年龄显著相关(-0.49),而在女性中与体重指数显著相关(0.34)。结论 本研究结果表明,维生素D活性与骨密度呈负相关,在老年男性中降低,而在肥胖女性中增强。